Codexis, Inc. (CDXS) NASDAQ
2.58
+0.12(+4.88%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.58
+0.12(+4.88%)
Currency In USD
| Previous Close | 2.46 |
| Open | 2.46 |
| Day High | 2.58 |
| Day Low | 2.4 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.96 |
| Volume | 900,507 |
| Average Volume | 2.35M |
| Market Cap | 234.51M |
| PE | -7.37 |
| EPS | -0.35 |
| Moving Average 50 Days | 2.21 |
| Moving Average 200 Days | 2.05 |
| Change | 0.12 |
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
GlobeNewswire Inc.
Feb 25, 2026 2:00 PM GMT
REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial resu
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
GlobeNewswire Inc.
Feb 17, 2026 2:00 PM GMT
REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the TD Cowen 4
Codexis Achieves ISO 9001:2015 Certification
GlobeNewswire Inc.
Feb 10, 2026 2:00 PM GMT
REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned its ISO 9001:2015 certification